Convergence Investment Partners LLC Acquires Shares of 45,622 Sabra Healthcare REIT, Inc. $SBRA

Convergence Investment Partners LLC acquired a new stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRAFree Report) during the 3rd quarter, HoldingsChannel.com reports. The firm acquired 45,622 shares of the real estate investment trust’s stock, valued at approximately $850,000.

Other hedge funds have also recently modified their holdings of the company. Focus Partners Wealth grew its stake in Sabra Healthcare REIT by 11.4% during the first quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock valued at $404,000 after acquiring an additional 2,375 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its position in shares of Sabra Healthcare REIT by 23.6% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 12,748 shares of the real estate investment trust’s stock valued at $237,000 after purchasing an additional 2,433 shares in the last quarter. Hilltop National Bank purchased a new position in shares of Sabra Healthcare REIT during the second quarter valued at about $96,000. Ameritas Advisory Services LLC bought a new stake in shares of Sabra Healthcare REIT in the second quarter worth about $84,000. Finally, QRG Capital Management Inc. lifted its position in shares of Sabra Healthcare REIT by 8.9% in the second quarter. QRG Capital Management Inc. now owns 66,212 shares of the real estate investment trust’s stock worth $1,221,000 after buying an additional 5,416 shares in the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on SBRA. Weiss Ratings restated a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Thursday, January 22nd. Wells Fargo & Company boosted their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. National Bankshares set a $22.00 price objective on shares of Sabra Healthcare REIT in a research report on Friday, October 17th. UBS Group initiated coverage on shares of Sabra Healthcare REIT in a report on Tuesday, November 18th. They issued a “neutral” rating and a $20.00 target price on the stock. Finally, Jefferies Financial Group restated a “buy” rating and set a $22.00 target price on shares of Sabra Healthcare REIT in a research report on Monday, December 15th. Four equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $21.11.

Get Our Latest Report on Sabra Healthcare REIT

Sabra Healthcare REIT Stock Down 2.5%

NASDAQ SBRA opened at $18.26 on Tuesday. The company has a quick ratio of 5.19, a current ratio of 5.19 and a debt-to-equity ratio of 0.92. Sabra Healthcare REIT, Inc. has a 52 week low of $15.60 and a 52 week high of $19.97. The firm has a market capitalization of $4.55 billion, a price-to-earnings ratio of 25.36, a PEG ratio of 1.30 and a beta of 0.67. The company has a fifty day moving average of $19.04 and a two-hundred day moving average of $18.71.

Sabra Healthcare REIT (NASDAQ:SBRAGet Free Report) last released its quarterly earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.01. The firm had revenue of $190.04 million during the quarter, compared to analysts’ expectations of $193.44 million. Sabra Healthcare REIT had a net margin of 23.50% and a return on equity of 6.38%. The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. On average, analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 27th. Stockholders of record on Friday, February 13th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 6.6%. The ex-dividend date is Friday, February 13th. Sabra Healthcare REIT’s dividend payout ratio is presently 166.67%.

Sabra Healthcare REIT Company Profile

(Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.

Recommended Stories

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRAFree Report).

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.